Having Poorly and Well Controlled Type 2 Diabetes with Chronic Periodontitis: a 3-month evaluation

Abstract

Aim: To evaluate the effect of nonsurgical periodontal therapy on serum C-reactive protein(CRP), interlökin-6 (IL-6) levels and periodontal parameters in patients with poorly and wellcontrolled type 2 diabetes with chronic periodontitis.Methods: Forty-five patients were included in the study. Of the 45, 30 had type 2 diabetesmellitus with chronic periodontitis (group 1A; poorly controlled group, n = 15, HbA1c ≥ 7%and group 1B; well controlled group, n = 15, HbA1c < 7%) and 15 were systemically healthy(group 2) with chronic periodontitis. Plaque index, gingival index, probing depth, clinicalattachment loss, gingival bleeding index scores, serum CRP and IL-6 concentrations weremeasured at baseline and 3 months after the nonsurgical periodontal therapy. Results: After the nonsurgical periodontal therapy all periodontal parameters and CRP and IL6 levels decreased significantly by the third month compared to baseline values in all groups.No statistically significant difference was determined among the groups between baseline andthird-month periodontal parameters, or in CRP or IL-6 levels after nonsurgical periodontaltherapy. Conclusion: Improvement in periodontal health is effective on control of systemic infectionvia reducing serum concentrations of CRP and IL-6 in patients with poorly and well controlledtype 2 diabetes with chronic periodontitis. The effects of nonsurgical periodontal treatmentseems to be independent of the degree of diabetic status

Keywords

• CRP,IL-6,periodontal therapy,periodontitis,type 2 diabetes mellitus

Kronik Periodontitisi Olan Kötü ve İyi Kontollü Tip 2 Diabet Hastalarında Periodontal Tedavinin Serum CRP ve IL-6 Seviyeleri Üzerine Etkisinin Değerlendirilmesi; 3 aylık bir değerlendirme

Abstract

Amaç: Kronik periodontitisi olan kötü ve iyi kontrollü tip 2 diabetik hastalarda cerrahi olmayan periodontal tedavinin serum C-reactif protein (CRP), interlökin-6 (IL-6) ve periodontal parametreler üzerine etkisinin değerlendirilmesidir. Method: Çalışmaya 45 hasta dahil edildi. 30 hasta kronik periodontitisi olan tip 2 diabet hastası idi.( grup 1A; kötü kontrollü grup, n=15, HbA1c ≥ 7% ve grup 1B; iyi kontrollü grup, n=15, HbA1c < 7%) ve 15 hasta ise kronik periodontitisi olan sistemik olarak sağlıklı hastalar (grup 2) idi. Plak indeksi, gingival indeks, cep derinliği, klinik ataçman kaybı, gingival kanama skorları, serum CRP ve IL-6 konsantrasyonları başlangıçta ve cerrahi olmayan periodontal tedaviden 3 ay sonra ölçüldü. Bulgular: Bütün gruplarda cerrahi olmayan periodontal tedaviden 3 ay sonra başlangıca göre tüm periodontal parametrelerde, serum CRP ve IL-6 seviyelerinde anlamlı azalma elde edildi. Grupların başlangıç ve 3. ay değerleri karşılaştırıldığında ise periodontal parametreler ile serum CRP ve IL-6 seviyelerinde herhangi bir fark tespit edilmedi. Sonuç: Kötü ve iyi kontrollü tip 2 diabetik hastalardaki periodontal iyileşme, serum CRP ve IL-6 konsantrasyonlarında azalmaya neden olarak sistemik infeksiyonun kontrol altına alınmasında etkilidir. Cerrahi olmayan periodontal tedavinin etkisinin diabetik durumun derecesinden bağımsız olduğu görülmektedir.

Keywords

• CRP,IL-6,periodontal tedavi,periodontitis,tip 2 diabetes mellitus.

References

1. Iacopıno AM: Periodontitis and diabetes interrelationships: Role of inflammation. Ann Periodontol 6:125-137, 2001.
2. Löe H: Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 16: 329 -334, 1993.
3. Iacopıno AM: Periodontitis and Diabetes Interrelationships: Role of Inflammation. Ann Periodontol 6:125 -137, 2001.
4. Nishimura F, Soga Y, Iwamoto Y, Kudo C, Murayama Y: Periodontal disease as part of the insulin resistance syndrome in diabetic patients. J Int Acad Periodontol 7:16-20, 2005.
5. D’aıuto F, Ready D, Tonetti Ms: Periodontal disease and C- reactive protein-associated cardiovascular risk. J Periodontal Res 39:236-242, 2004.
6. Southerland Jh, Taylor Gw, Offenbacher S: Diabetes and periodontal infection: Making the connection. Clin Diabetes 23:171-178, 2005.
7. Southerland JH, Taylor GW, Moss K, Beck JD, Offenbacher S: Commonality In Chronic Inflammatory Diseases: Periodontitis, Diabetes, And Coronary Artery Disease. Periodontology 40: 130–143, 2006.
8. Schmidt AM, Weidman E, Lalla E, et al: Advanced glycation end-products (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 31:508– 515, 1996.

9. Matthews DC: The Relationship Between Diabetes and Periodontal Disease. J Can Dent Assoc 68:161 -164, 2002.
10. Sjöholm A, Nyström T: Inflammation and the etiology of type 2 diabetes.Diabetes Metab Res Rev 22:4-10, 2006.
11. Amar S, Han X: The impact of periodontal infection on systemic diseases. Med Sci Monit 9:291-299, 2003.
12. Ryan M, Carnu O, Tenzler R: The impact of periodontitis on metabolic control and risk for diabetic complications. Grand Rounds Oral-Sys Med 2:24-34, 2006.
13. Mealey BL: Periodontal disease and diabetes: A two-way street. J Am Dent Assoc 137:26-31, 2006.
14. Hillman N, Herranz L, Grande C, Villaroel A, Pallardo LF: Is HbA1C influenced more strongly by preprandial or postprandial glycemia in type 1 diabetes? Diabetes Care 25:1100-1101, 2002.
15. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, 3-5 June 1997. Geneva: World Health Organization, WHO/NCD/98, 1. 1998.
16. Altuntas Y: Diagnosis, monitoring tests and methods in diabetes mellitus. In: All Aspects of Diabetes Mellitus (Yenigün M, ed.). Istanbul. Tayf Press, pp: 63-68, 2001
17. Sillness J, Löe H: Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22:121-135, 1964.
18. Löe H, Silness J: Periodontal disease in pregnancy I. Prevalance and severity. Acta Odontol Scand 21:533-551, 1963.
19. Ainamo J, Bay I: Problems and proposal for recording gingivitis and plaque. Int Dent I 25:229-235, 1975.
20. Christgau M, Palitzch K-D, Schmalz G, Kreiner U, Frenzel S: Healing response to on-surgical periodontal therapy in patients with diabetes mellitus: Clinical, microbiological, and immunologic results. J Clin Periodontol 25:112-124, 1998.
21. Kadiroglu AK, Kadiroglu ET, Şit D, Dag A, Yilmaz ME: Periodontitis is an important and occult source of inflammation in hemodialysis patients. Blood Purif 24:400-404, 2006.
22. Chin-Der C, Hsin-Fu C, Hsin-Fen L, et al: Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome. Hum Reprod 15:1037-1042, 2000.
23. Libby P, Plutzky J: Diabetic macrovascular disease: the glucose paradox [comment]?, Circulation 106: 2760–2763, 2002.
24. Kurtis B, Develioglu H, Taner Il, Balos K, Tekin IO: IL-6 levels in gingival crevicular fluid (GCF) from patients with non- insulin dependent diabetes mellitus (NIDDM), adult periodontitis and healthy subjects, J Oral Sci 41:163–167, 1999.
25. Janket SJ, Jones JA, Meurman JH, Baird AE, Van Dyke TE: Oral infection, hyperglycemia, and endothelial dysfunction. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 105:173-179, 2008.
26. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A: Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 34:835-843, 2007.
27. Rodrigues DC, Taba M, Novaes AB, Souza SlS, Grisi MFM: Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 74:1361-1367, 2003.
28. Grossi SG, Skrepcinski FB, Decaro T, et al: Therapy of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 68:713-719, 1997.
29. Tervonen T, Karjalainen K: Periodontal disease related to diabetic status: A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol 24:505-510, 1997.
30. Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J: The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol 23: 92 -100, 1996.
31. Pickup JC, Chusney GD, Thomas SM, Burt D: Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci 67:291-300, 2000.
32. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C- reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001.
33. Wakai K, Kawamura T, Umemura O, et al: Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol 26:664-672, 1999.
34. Loos BG, Craandijk J, Hoek FJ, et al: Elevation of systemic markers related to cardiovascular disease in the peripheral blood of periodontitis patients. J Periodontol 71:1528-1534, 2000.
35. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS: Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 79:49-57, 2000.
36. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT: Examination of the relation between periodontal health status and cardiovascular risk factors: Serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol 151:273-282, 2000.
37. Noack B, Genco Rj, Trevisan M, et al: Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72:1221-1227, 2001.
38. Glurich I, Grossi S, Albini B, et al: Systemic inflammation in cardiovascular and periodontal disease: Comparative study. Clin Diagn Lab Immunol 9:425-432, 2002.
39. Saito T, Murakami M, Shimazaki Y, Oobayashi K: Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J Periodontol 74:1741-1746, 2003.
40. D’aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS: Short- term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 84:269-273, 2005.
41. Mattila K, Vesanen M, Nieminen M, et al: Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis 2:30, 2002.
42. Yamazaki K, Honda T, Oda T, et al: Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 40:53-58, 2005.
43. Talbert J, Elter J, Jared HL, Offenbacher S, Southerland J, Wilder RS: The effect of periodontal therapy on TNF-alpha, IL-6 and metabolic control in type 2 diabetics. J Dent Hyg 80:7, 2006.
44. Ide M, Mcpartlin D, Coward PY, et al: Effect of treatment of chronic periodontis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol 30:334-340, 2003.